This study is testing if a device called the THOR LED Photobiomodulation Helmet can help improve "chemo brain" or cancer-related cognitive impairment (problems with thinking, memory, and focus after cancer treatment). You might be able to join if you are an adult (18 or older) who has had certain types of cancer (stage I-III non-central nervous system solid tumor, Hodgkin, or Non-Hodgkin lymphoma) and finished your main cancer treatment (chemotherapy and/or radiation) between 6 months and 5 years ago. The study aims to see if using this helmet can positively impact cognitive symptoms. The current status of this study is unclear, and it plans to enroll 30 participants.

Study design

This is a pilot, randomized, double-blinded study with 30 participants. Participants will be assigned by chance to either receive the active treatment or a placebo (inactive) treatment.

What's involved

Participants will use the helmet device three times a week for six weeks. You will need to sit with the helmet on your head during each session, and protective goggles will be worn.

Compensation

Not stated in the trial record.

Follow-up

Your cognitive symptoms will be measured at a 1-month follow-up after the treatment period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.